US 11179352
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted A61KA61K31/137A61P
Quick answer
US patent 11179352 (Dosage forms and methods for enantiomerically enriched or pure bupropion) held by AXSOME THERAPEUTICS, INC. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/137, A61P, A61P25/28